Latest Metformin Stories
University of Texas Medical Branch at Galveston researchers have discovered that a drug already prescribed to millions of people with diabetes could also have another important use: treating one of the world's leading causes of blindness.
A new study, published Sunday in the New England Journal of Medicine (NEJM), reveals that a combination treatment may be the best way to treat type 2 diabetes in children and adolescents.
An international team of scientists has discovered a link between the active ingredient in aspirin and a protein which helps regulate cell growth and metabolism -- a link which could mean that the same anti-inflammatory medication and pain reliever might potentially be able to help treat cancer and prevent Type 2 Diabetes.
Patients suffering from type 2 diabetes may not benefit from taking both an oral glucose lowering drug (metformin) and insulin instead of insulin alone.
A major 12-year study based on a Taiwanese population cohort has demonstrated that not only does diabetes increase the risk of developing Parkinson's disease more than 2-fold, the use of sulfonylureas, commonly used as treatment for diabetes, increases the risk further by about 57%.
Although the drug metformin is considered the gold standard in the management of type 2 diabetes, a study by a group of French researchers published in this week's PLoS Medicine suggests that the long-term benefits of this drug compared with the risks are not clearly established—an important finding given that currently, thousands of people around the world are regularly taking metformin to help control their blood sugar levels in the belief that it also has long-lasting health benefits.
- The act of sweetening by admixture of some saccharine substance.